CD274 and renal cell adenocarcinoma: For example, Minami et al. showed by using PD-L111-19 and PD-L141-50 peptides that PD-L1-specific CTLs were induced in patients with renal cell cancer to kill PD-L1-expressing tumor cells in an HLA-A24-restricted manner [25].